Loading...
Home 2018-04-20T08:02:01+00:00
Explore our services

Drug Formulation & Characterization

Our pharmaceutical unit has comprehensive knowhow about small molecules, biologics and ingredients.

Human Disease
Models

We are in the forefront of disease model development with a variety of immune, iPSC-derived and immortalized cell line-based models.

Recombinant
Proteins

We produce, purify and characterize recombinant proteins using prokaryotic and eukaryotic gene expression systems.

Molecular Histology
& Detection

We offer a broad spectrum of technologies from single cell analysis to complex histology and specialized RNA in situ detection.

Research & Development

The R&D strategy of Bioneer is focused on therapeutic fields where novel solutions are required to fulfill societal needs. Treatments of the future require that patients can be segmented, that specific disease pathogenesis can be explained, that mode-of-action mechanisms can be understood and that therapeutic modalities are tailored to provide optimal treatment effects.

Bioneer welcomes novel collaborations and encourages potential collaborators to contact Bioneer.

Contact us for more information

The R & D Program Includes:

Research & development

The R&D strategy of Bioneer for 2016 and onwards is focused on therapeutic fields where novel solutions are required to fulfill societal needs. Treatments of the future requires that diseases can be segmented, that mode-of-action patterns of diseases can be understood and that therapeutic modalities are tailored to provide optimal treatment effects with a minimum of sideeffects.

In order to execute parts of this demanding research program Bioneer receives an annual grant from the Danish Ministry of Education and Research which alongside with Danish and international industrial grants, and internal funding forms the financial basis for realizing the program.

Bioneer welcomes novel collaborations and encourage potential collaboratiors to contact bioneer.

The R & D program includes:

Contact us for more information

Latest news

New Bioneer website

Bioneer is excited to launch a new refreshed website. We hope our visitors will appreciate the ease of navigating and way of orientation among th [...]

New CEO at Bioneer

Lars Hagsholm Pedersen replaces Poul Andersson who retired on March 31st 2018 after nearly 15 successful years as a highly respected leader. Po [...]

Read latest publications

Meet us at

Create new product opportunities

We offer access to essential tools, technology and unique biological resources within cell and molecular biology.

Contact Us